Flurazepam Impurity 2 | CAS 100234-75-1 - Request Quote
Flurazepam Impurity 2
| SZ CAT No: | SZ-F103008 |
| CAS No | 100234-75-1 |
| Mol.F. | C21H23ClFN3O |
| Mol.Wt. | 387.9 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Flurazepam Impurity 2 is chemically 3-Amino-6-chloro-1-(2-(diethylamino)ethyl)-4-(2-fluorophenyl)quinolin-2(1H)-one. Flurazepam Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Flurazepam Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Flurazepam.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 100234-75-1
Purchase 100234-75-1
Order 100234-75-1
Enquire 100234-75-1
price of 100234-75-1
100234-75-1 Supplier
100234-75-1 Manufacturer
100234-75-1 Exporter
buy high quality Flurazepam Impurity 2
Purchase Flurazepam Impurity 2
Flurazepam Impurity 2 suppliers
Flurazepam Impurity 2 manufacturers
Flurazepam Impurity 2 price
Order Flurazepam Impurity 2
Enquire Flurazepam Impurity 2
Flurazepam Impurity 2 cost
Flurazepam Impurity 2 Supplier
Flurazepam Impurity 2 Distributor
Flurazepam Impurity 2 for Method Validation
Flurazepam Reference Standard
Flurazepam Impurity 2 for ANDA Filing
Flurazepam Impurity 2 for Forced Degradation Studies
Flurazepam Impurity 2 Identification Standards
Flurazepam Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


